Stock DNA
Pharmaceuticals & Biotechnology
USD 1,338 Million (Small Cap)
7.00
NA
0.00%
-0.81
28.44%
2.13
Total Returns (Price + Dividend) 
InMode Ltd. for the last several years.
Risk Adjusted Returns v/s 
News

InMode Ltd. Experiences Revision in Stock Evaluation Amid Mixed Market Signals
InMode Ltd., a small-cap company in the Pharmaceuticals and Biotechnology sector, has seen its stock price rise slightly to $15.65. The company has experienced notable volatility over the past year, with a 52-week high of $19.85 and a low of $13.14, while its performance has lagged behind the S&P 500.
Read MoreIs InMode Ltd. technically bullish or bearish?
As of 24 October 2025, the technical trend for InMode Ltd. has changed from mildly bullish to sideways. The current stance is neutral, with mixed signals across different indicators. The weekly MACD and KST are mildly bullish, while the daily moving averages indicate a mildly bearish trend. The Bollinger Bands show a mildly bullish signal on the weekly but a mildly bearish signal on the monthly. Dow Theory presents a mildly bearish view on the weekly but is mildly bullish on the monthly. In terms of performance, InMode has underperformed the S&P 500 across multiple periods, with a year-to-date return of -8.32% compared to the S&P 500's 15.47%, and a one-year return of -13.5% versus 16.90% for the index....
Read MoreIs InMode Ltd. technically bullish or bearish?
As of 24 October 2025, the technical trend for InMode Ltd. has changed from mildly bullish to sideways. The current stance is neutral, with mixed signals across various indicators. The MACD shows a mildly bullish trend on both weekly and monthly time frames, while the Bollinger Bands indicate a mildly bullish weekly outlook but a mildly bearish monthly perspective. The moving averages are pointing mildly bearish on a daily basis. The KST is bullish weekly and mildly bullish monthly, while the Dow Theory presents a mildly bearish weekly view but a mildly bullish monthly perspective. The OBV shows no trend weekly but is mildly bullish monthly. Overall, the mixed signals suggest a lack of clear direction. Multi-period return data is not available for comparison with the S&P 500....
Read More Announcements 
Corporate Actions 
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2025
Shareholding Compare (%holding) 
Domestic Funds
Held in 99 Schemes (24.51%)
Held by 150 Foreign Institutions (23.54%)
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY
YoY Growth in quarter ended Jun 2025 is 10.65% vs -36.52% in Jun 2024
YoY Growth in quarter ended Jun 2025 is 12.18% vs -57.27% in Jun 2024
Annual Results Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is -19.76% vs 8.30% in Dec 2023
YoY Growth in year ended Dec 2024 is -8.39% vs 22.54% in Dec 2023






